Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 107Precursor Cell Lymphoblastic Leukemia-Lymphoma 38Leukemia 23Lymphoma 20Recurrence 16Burkitt Lymphoma 16Lymphoma, Mantle-Cell 13Neoplasms, Plasma Cell 11Lymphoma, Non-Hodgkin 11Waldenstrom Macroglobulinemia 9Lymphoma, Follicular 9Immunoglobulin Light-chain Amyloidosis 9Hodgkin Disease 9Breast Neoplasms 9Vomiting 8Neoplasms 8Nausea 8Lymphoma, B-Cell, Marginal Zone 8Lymphoma, Large B-Cell, Diffuse 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, T-Cell, Cutaneous 6Leukemia, Lymphocytic, Chronic, B-Cell 6Amyloidosis 6Leukemia, Myeloid, Acute 5Smoldering Multiple Myeloma 4Sezary Syndrome 4Mycosis Fungoides 4Lymphoma, Large-Cell, Immunoblastic 4Lung Neoplasms 4Blast Crisis 4

Interventions

Dexamethasone 2ixazomib 1birtamimab 1Standard of Care 1Rosiglitazone 1Neurofeedback 1Methotrexate 1Melphalan 1Mass Screening 1Magnetic Resonance Imaging 1Lysine Acetyltransferase 5 1Hormones 1Exercise 1Cyclophosphamide 1Control Groups 1Cholinesterase Inhibitors 1Calcium Dobesilate 1Bortezomib 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Alzheimer Disease × Calcium Dobesilate × Clear all
NCT01083316 2020-09-25

Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis

Boston Medical Center

Phase 2 Completed
35 enrolled 9 charts
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡